Cargando…

Monoclinic modification of bis­(μ(2)-pyridine-2,6-dicarboxyl­ato)-κ(4) O (2),N,O (6):O (6);κ(4) O (2):O (2),N,O (6)-bis­[aqua­dibutyl­tin(IV)]

The Sn(IV) atom in the centrosymmetric dinuclear title compound, [Sn(2)(C(4)H(9))(4)(C(7)H(3)NO(4))(2)(H(2)O)(2)], exists in a trans-C(2)SnNO(4) penta­gonal–bipyramidal geometry. There are two half-mol­ecules in the asymmetric unit that are completed by inversion symmetry. The crystal studied was a...

Descripción completa

Detalles Bibliográficos
Autor principal: Ng, Seik Weng
Formato: Texto
Lenguaje:English
Publicado: International Union of Crystallography 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3051593/
https://www.ncbi.nlm.nih.gov/pubmed/21522924
http://dx.doi.org/10.1107/S1600536811002935
_version_ 1782199515899494400
author Ng, Seik Weng
author_facet Ng, Seik Weng
author_sort Ng, Seik Weng
collection PubMed
description The Sn(IV) atom in the centrosymmetric dinuclear title compound, [Sn(2)(C(4)H(9))(4)(C(7)H(3)NO(4))(2)(H(2)O)(2)], exists in a trans-C(2)SnNO(4) penta­gonal–bipyramidal geometry. There are two half-mol­ecules in the asymmetric unit that are completed by inversion symmetry. The crystal studied was a non-merohedral twin with a ratio of 47.3 (1)% for the minor twin component. Bond dimensions are similar to those found in the tetra­gonal polymorph [Huber et al. (1989 ▶). Acta Cryst. C45, 51–54]. O—H⋯O hydrogen-bonding interactions stabilize the crystal packing.
format Text
id pubmed-3051593
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-30515932011-04-26 Monoclinic modification of bis­(μ(2)-pyridine-2,6-dicarboxyl­ato)-κ(4) O (2),N,O (6):O (6);κ(4) O (2):O (2),N,O (6)-bis­[aqua­dibutyl­tin(IV)] Ng, Seik Weng Acta Crystallogr Sect E Struct Rep Online Metal-Organic Papers The Sn(IV) atom in the centrosymmetric dinuclear title compound, [Sn(2)(C(4)H(9))(4)(C(7)H(3)NO(4))(2)(H(2)O)(2)], exists in a trans-C(2)SnNO(4) penta­gonal–bipyramidal geometry. There are two half-mol­ecules in the asymmetric unit that are completed by inversion symmetry. The crystal studied was a non-merohedral twin with a ratio of 47.3 (1)% for the minor twin component. Bond dimensions are similar to those found in the tetra­gonal polymorph [Huber et al. (1989 ▶). Acta Cryst. C45, 51–54]. O—H⋯O hydrogen-bonding interactions stabilize the crystal packing. International Union of Crystallography 2011-01-29 /pmc/articles/PMC3051593/ /pubmed/21522924 http://dx.doi.org/10.1107/S1600536811002935 Text en © Seik Weng Ng 2011 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
spellingShingle Metal-Organic Papers
Ng, Seik Weng
Monoclinic modification of bis­(μ(2)-pyridine-2,6-dicarboxyl­ato)-κ(4) O (2),N,O (6):O (6);κ(4) O (2):O (2),N,O (6)-bis­[aqua­dibutyl­tin(IV)]
title Monoclinic modification of bis­(μ(2)-pyridine-2,6-dicarboxyl­ato)-κ(4) O (2),N,O (6):O (6);κ(4) O (2):O (2),N,O (6)-bis­[aqua­dibutyl­tin(IV)]
title_full Monoclinic modification of bis­(μ(2)-pyridine-2,6-dicarboxyl­ato)-κ(4) O (2),N,O (6):O (6);κ(4) O (2):O (2),N,O (6)-bis­[aqua­dibutyl­tin(IV)]
title_fullStr Monoclinic modification of bis­(μ(2)-pyridine-2,6-dicarboxyl­ato)-κ(4) O (2),N,O (6):O (6);κ(4) O (2):O (2),N,O (6)-bis­[aqua­dibutyl­tin(IV)]
title_full_unstemmed Monoclinic modification of bis­(μ(2)-pyridine-2,6-dicarboxyl­ato)-κ(4) O (2),N,O (6):O (6);κ(4) O (2):O (2),N,O (6)-bis­[aqua­dibutyl­tin(IV)]
title_short Monoclinic modification of bis­(μ(2)-pyridine-2,6-dicarboxyl­ato)-κ(4) O (2),N,O (6):O (6);κ(4) O (2):O (2),N,O (6)-bis­[aqua­dibutyl­tin(IV)]
title_sort monoclinic modification of bis­(μ(2)-pyridine-2,6-dicarboxyl­ato)-κ(4) o (2),n,o (6):o (6);κ(4) o (2):o (2),n,o (6)-bis­[aqua­dibutyl­tin(iv)]
topic Metal-Organic Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3051593/
https://www.ncbi.nlm.nih.gov/pubmed/21522924
http://dx.doi.org/10.1107/S1600536811002935
work_keys_str_mv AT ngseikweng monoclinicmodificationofbism2pyridine26dicarboxylatok4o2no6o6k4o2o2no6bisaquadibutyltiniv